Predictive Oncology Inc. entered into a Standby Equity Purchase Agreement on July 1, 2025, allowing it to sell up to $10 million in common stock to YA II PN, Ltd.; they received a structuring fee of $25,000 and issued 120,482 shares as a commitment fee.